STROKE

Stroke is the fourth leading cause of death and leading cause of adult disability. There remains an urgent need for additional acute therapies.

Pharmidex are now offering in life work for stroke and our goal is to test and identify potential candidates that can be advanced to the clinical trials.

Pharmidex specialises in conducting preclinical studies for testing potential therapeutic agents for their ability to elicit neuroprotection.

Areas of Expertise

• Bespoke services to evaluate novel therapeutic agents for their neuroprotective ability

• Conducting histological studies alongside extensive, long-term assessments to evaluate functional and cognitive outcomes

• Assessment of pharmacokinetics and pharmacodynamic properties of novel agents
  

Stroke Models

We offer two different models of ischemia: 

• Transient cerebral ischemia (filament model)

• Permanent focal ischemia model (coagulation model)